Kura Oncology (KURA) Accumulated Depreciation (2014 - 2026)
Kura Oncology (KURA) reported Accumulated Depreciation of $3.61 million for Q2 2026, down 3.5% from $3.74 million a year earlier but up 11.4% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Accumulated Depreciation (2014 - 2026) Analysis & Trends
At the end of FY2025, Kura Oncology posted Accumulated Depreciation of $2.9 million, down 11.5% from FY2024.
- Accumulated Depreciation has a five-year compound annual growth rate of 58.9% (FY2020 to FY2025).
- By year, Accumulated Depreciation came in at $3.28 million in FY2024 (+33.6%), $2.45 million in FY2023 (+53.0%), $1.6 million in FY2022 (+89.9%) and $844,000 in FY2021 (+195.1%).
- Five-year quarterly Accumulated Depreciation spans a low of $678,000 in Q3 2021 and a high of $3.87 million in Q3 2025.
- Year over year, Accumulated Depreciation has now declined in each of the last three quarters, with growth averaging 17.1% over the last eight quarters.
- The high point for year-over-year Accumulated Depreciation in five years was Q3 2021 (growth of 280.9%); the low point was Q4 2025 (a decline of 11.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.24 million (Q1 2026), $2.9 million (Q4 2025) and $3.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Kura Oncology | 947.36 Mn | 947.36 Mn | 20.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.61 Mn |
| Mar 31, 2026 | 3.24 Mn |
| Dec 31, 2025 | 2.90 Mn |
| Sep 30, 2025 | 3.87 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 2.86 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 2.24 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | 1.81 Mn |
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 844,000.00 |
| Sep 30, 2021 | 678,000.00 |
API Access
Kura Oncology Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();